Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,669
Total Claims
$960K
Drug Cost
661
Beneficiaries
$1,452
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+3%
Cost per patient vs peers
$1,452 vs $1,411 avg
+33%
Brand preference vs peers
14.1% vs 10.6% avg
Brand vs Generic
Brand: 2,068 claims · $746K
Generic: 12,553 claims · $212K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Glargine,hum.Rec.Anlog | 271 | $98K |
| Sitagliptin Phosphate | 87 | $82K |
| Empagliflozin | 65 | $66K |
| Apixaban | 81 | $62K |
| Linagliptin | 52 | $55K |
| Levothyroxine Sodium | 627 | $54K |
| Sitagliptin Phos/Metformin Hcl | 71 | $52K |
| Rivaroxaban | 44 | $51K |
| Dulaglutide | 28 | $34K |
| Dapagliflozin Propanediol | 33 | $21K |
| Sitagliptin Phos/Metformin Hcl | 34 | $20K |
| Insulin Lispro Protamin/Lispro | 16 | $17K |
| Insulin Nph Hum/Reg Insulin Hm | 48 | $15K |
| Insulin Lispro | 24 | $12K |
| Atorvastatin Calcium | 876 | $11K |
Prescribing Profile
Patient Profile
75
Avg Age
62%
Female
1.32
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data